Anti-I12R1/ IL12RB1/ CD212 monoclonal antibody

Anti-I12R1/ IL12RB1/ CD212 antibody for FACS & in-vivo assay

Target products collectionGo to IL12RB1/IL12RB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IO073-Ab-1/ GM-Tg-hg-IO073-Ab-2Anti-Human IL12RB1 monoclonal antibodyHuman
GM-Tg-rg-IO073-Ab-1/ GM-Tg-rg-IO073-Ab-2Anti-Rat IL12RB1 monoclonal antibodyRat
GM-Tg-mg-IO073-Ab-1/ GM-Tg-mg-IO073-Ab-2Anti-Mouse IL12RB1 monoclonal antibodyMouse
GM-Tg-cynog-IO073-Ab-1/ GM-Tg-cynog-IO073-Ab-2Anti-Cynomolgus/ Rhesus macaque IL12RB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IO073-Ab-1/ GM-Tg-felg-IO073-Ab-2Anti-Feline IL12RB1 monoclonal antibodyFeline
GM-Tg-cang-IO073-Ab-1/ GM-Tg-cang-IO073-Ab-2Anti-Canine IL12RB1 monoclonal antibodyCanine
GM-Tg-bovg-IO073-Ab-1/ GM-Tg-bovg-IO073-Ab-2Anti-Bovine IL12RB1 monoclonal antibodyBovine
GM-Tg-equg-IO073-Ab-1/ GM-Tg-equg-IO073-Ab-2Anti-Equine IL12RB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IO073-Ab-1/ GM-Tg-hg-IO073-Ab-2; GM-Tg-rg-IO073-Ab-1/ GM-Tg-rg-IO073-Ab-2;
GM-Tg-mg-IO073-Ab-1/ GM-Tg-mg-IO073-Ab-2; GM-Tg-cynog-IO073-Ab-1/ GM-Tg-cynog-IO073-Ab-2;
GM-Tg-felg-IO073-Ab-1/ GM-Tg-felg-IO073-Ab-2; GM-Tg-cang-IO073-Ab-1/ GM-Tg-cang-IO073-Ab-2;
GM-Tg-bovg-IO073-Ab-1/ GM-Tg-bovg-IO073-Ab-2; GM-Tg-equg-IO073-Ab-1/ GM-Tg-equg-IO073-Ab-2
Products NameAnti-IL12RB1 monoclonal antibody
Formatmab
Target NameIL12RB1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL12RB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species I12R1/ IL12RB1/ CD212 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-IO073-Ag-1interleukin 12 receptor, beta 1 (IL12RB1) protein


    Target information

    Target IDGM-IO073
    Target NameIL12RB1
    Gene ID3594,16161,171333,574199,484828,101093085,524299,100146965
    Gene Symbol and SynonymsCD212,IL-12R,IL-12R-beta-1,IL-12R-BETA1,IL-12R[b],IL12RB,IL12RB1,IMD30
    Uniprot AccessionP42701
    Uniprot Entry NameI12R1_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000096996
    Target ClassificationCheckpoint-Immuno Oncology, Cytokine Receptor

    The target: IL12RB1, gene name: IL12RB1, also named as CD212, IL-12R-BETA1, IL12RB, IMD30. The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.